Prevalence and concordance of early and sustained remission assessed by various validated indices in the early arthritis “ESPOIR” cohort - 06/01/15
, Bernard Combe a, Bruno Fautrel c, Nathalie Rincheval a, Cédric Lukas aBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Objectives |
To assess the prevalence of remission in early arthritis, to evaluate the concordance across different criteria sets in defining this state, and to look for predictive factors for early and sustained remission.
Methods |
Patients from the ESPOIR cohort were followed-up every 6months. We analysed early remission and sustained remission in 3 groups of patients: patients having rheumatoid arthritis (RA) according to 2010 ACR/EULAR criteria, undifferentiated arthritis (UA), and the whole cohort. Remission was defined according to ACR/EULAR criteria, 28 Joint Disease Activity Score (DAS28<2.6), and Simplified Disease Activity Index (SDAI≤3.3). Agreement was evaluated by k-coefficient. Predictive factors for sustained remission at 1, 3 and 5year in RA patients were analyzed.
Results |
Eight hundred and nineteen patients were included. Early remission rates in the RA/UA/ESPOIR groups were observed in respectively 29.2% (181/682), 51.4% (55/123) and 32.7% (239/813) of patients by DAS28; 15.7%, 29.1% and 18% by SDAI; and 11.2%, 29.1% and 12.8% by ACR/EULAR criteria. Agreement between classifications of remission was low for DAS28 vs. ACR/EULAR (k=0.44), high for SDAI vs. ACR/EULAR (k=0.78), and moderate for SDAI vs. DAS28 (k=0.54). Lower baseline disease activity scores, non-menopausal status and younger age were the best predictive factors for sustained remission, with consistent results across the 3 definitions of remission.
Conclusion |
Our study showed that the rate of early and sustained remission in early arthritis is dependent on the definition used, with a variable degree of agreement across criteria sets, but with consistent predictive factors of favourable outcome in patients finally diagnosed with RA.
Le texte complet de cet article est disponible en PDF.Keywords : Early rheumatoid arthritis, ESPOIR cohort, Remission criteria, Early remission, Sustained remission
Plan
Vol 81 - N° 5
P. 409-415 - octobre 2014 Retour au numéro
Article précédent
- Usefulness of bone density measurement in fallers
- Hubert Blain, Yves Rolland, Olivier Beauchet, Cedric Annweiler, Claude-Laurent Benhamou, Athanase Benetos, Gilles Berrut, Maurice Audran, Sauveur Bendavid, Valérie Bousson, Karine Briot, Michel Brazier, Véronique Breuil, Laure Chapuis, Roland Chapurlat, Martine Cohen-Solal, Bernard Cortet, Patricia Dargent, Patrice Fardellone, Jean-Marc Feron, Jean-Bernard Gauvain, Pascal Guggenbuhl, Olivier Hanon, Michel Laroche, Sami Kolta, Éric Lespessailles, Brigitte Letombe, Éric Mallet, Christian Marcelli, Philippe Orcel, François Puisieux, Patrick Seret, Jean-Claude Souberbielle, Bruno Sutter, Florence Trémollières, Georges Weryha, Christian Roux, Thierry Thomas, Pour le Groupe de recherche et d’information sur les ostéoporoses et la Société française de gérontologie et gériatrie
- High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis
- Anaïs Gardette, Sébastien Ottaviani, Florence Tubach, Carine Roy, Pascale Nicaise-Roland, Elisabeth Palazzo, Ghislaine Gill, Olivier Meyer, Philippe Dieudé
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?